Title21 Health Solutions announced today it was honored by CIO Review as a Top 20 Most Promising Biotech Technology Solution Provider.
Title21 Health Solutions was selected for their electronic data management solution that helps Biotech and other Health Science organizations streamline product development and manufacturing operations, close compliance gaps and improve overall quality. Title21 offers an integrated platform of solutions in Product Development and Manufacturing, Inventory Management, Document Control, Training, Quality Management, Audit, and more.
“Our sole focus is developing and implementing robust solutions for Health Sciences organizations from Biotech to Healthcare Providers. We provide powerful, easy-to-use solutions to help our partners develop and produce high quality products, realize operational efficiencies, comply with regulatory standards and ultimately deliver cutting-edge products and therapies that improve patient outcomes,” stated Lynn Fischer, CEO of Title21 Health Solutions. Each year, CIO Review’s panel of industry experts and thought leaders evaluate hundreds of solution providers. Companies are chosen according to their capability to fulfill business objectives through innovative products and services, integration of cutting-edge technologies, as well as being positioned at the forefront of tackling key challenges in the industry.
“Title21 Health Solutions has been on our radar for some time now for stirring a revolution in health technology space, and we are happy to showcase them this year due to their continuing excellence in delivering top-notch technology-driven solutions,” said Harvi Sachar, Publisher and Founder, CIO Review. “Title21 Health Solutions continued to break new ground within the past year benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”
